Phase II Study of Combined Treatment with Irinotecan and S-1 (IRIS) in Patients with Inoperable or Recurrent Advanced Colorectal Cancer (HGCSG0302)

Publisher： Karger

E-ISSN： 1423-0232|80|1-2|70-75

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.1-2, 2011-06, pp. : 70-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

Phase I Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 58-63

Karger

Access to resources Recommend Favorite

Phase II Study of a Combination of Irinotecan and S-1 in Patients with Advanced Gastric Cancer (OGSG0002)

By  

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 65-71

Karger

Access to resources Recommend Favorite

A Phase II Trial of Combined Chemotherapy with Oral S-1 and 24-Hour Infusions of Irinotecan plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 353-359

Karger

Access to resources Recommend Favorite

Phase I/II Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 219-225

Karger

Access to resources Recommend Favorite